The Risks and Dangers of Electronic Cigarettes

Aug.31.2022
The Risks and Dangers of Electronic Cigarettes
Electronic cigarettes are not a safe alternative to traditional smoking and may cause serious lung diseases.

For a long time, using e-cigarettes has been considered a reasonable option, as they are seen as a substitute for traditional cigarettes and a preferred choice for those who wish to quit smoking. Currently, e-cigarettes are facing scrutiny from the scientific community, and experts even suggest that they may be more harmful than traditional cigarettes.


According to a survey conducted by Covitel, a phone survey on risk factors for chronic non-communicable diseases during the pandemic, a significant portion of Brazilian youths use e-cigarettes. 19.7% of individuals aged 18 to 24 are followers of this device, which can be seen as one of the entry points for tobacco consumption.


Are electronic cigarettes riskier than regular cigarettes?


The Brazilian Society of Pathology (SBP) pathologist Alexandre Todorovic Fabro stated in a declaration that electronic cigarettes result in similar diseases as traditional cigarettes, as well as more severe conditions such as lung cell destruction due to combustion caused by the combination of hot steam and toxic substances.


Dr. Fabro compared the damage to lung tissue caused by electronic cigarettes to the toxic smoke inhalation experienced during fires, in order to provide evidence for the harm caused by e-cigarettes. He explained that in cases of this type of damage, "if the person does not die, they will develop pneumonia and leave marks on the lungs, much like internal scars.


In fact, there is a specific name for illnesses caused by the use of e-cigarettes: EVALI. In English, the full name for this term is e-cigarette or vaping product use-associated lung injury/illness, a term that has been in use since October 2019.


Other Complications Caused by Smoking


Aside from the unique diseases that electronic cigarettes may cause, they may also lead to the same issues as traditional cigarettes, such as lung cancer and chronic obstructive pulmonary disease (COPD) – previously known as emphysema. Concerning COPD, Paulo Antônio Morais Faleiros, a pulmonologist from SBP, explains that this is a preventable disease.


These two illnesses are most commonly seen among electronic cigarette users, but research linking this habit to an increased risk of over 10 types of cancer, including bladder cancer, has been conducted on cigarette smokers.


Electronic cigarettes can serve as a gateway to vaporizing.


Individuals who have been smoking for years do not prefer cigarettes with tutti-frutti scents or ones that taste like lemon pie. They prefer the taste and odor of tar. However, for those who have never smoked, these new flavors and aromas are clearly eye-catching," argued pulmonologist Dr. Faleiros.


At this point, it is difficult to observe that the device is actually a substitute for smoking cessation. On the other hand, research shows that electronic cigarettes are popular among young age groups, such as those aged 18 to 24.


Is the e-cigarette being released in Brazil?


It is important to note that Brazil has banned the use of electronic cigarettes. According to the Brazilian Medical Association (AMB) and the Federal Medical Council (CFM), legislation pertaining to electronic cigarettes should remain the same due to potential risks faced by users.


In July of this year, Brazil's National Health Surveillance Agency (Anvisa) declared that the ban on importing, advertising and selling electronic cigarettes and vaping devices would remain in effect following the release of a report on the subject. Despite these measures being taken, illegal sales of e-cigarettes and vaping devices continue to occur throughout the country.


Statement: 1. This article is compiled based on third-party information and is intended for industry exchange and learning. 2. The views expressed in this article do not represent the views of 2FIRSTS and 2FIRSTS cannot confirm the authenticity and accuracy of the article contents. The compilation of this article is only for industry exchange and research. 3. Due to the limitations of the compilation level, the compiled article may not express the same views as the original text, so please refer to the original text for accuracy. 4. Regarding any statements or positions related to domestic, Hong Kong, Macao, Taiwan, and foreign affairs, 2FIRSTS maintains full consistency with the Chinese government. 5. Copyright ownership of the compiled information belongs to the original media and authors. If any infringement is found, please contact us for removal.


This document has been generated through artificial intelligence translation and is provided solely for the purposes of industry discourse and learning. Please note that the intellectual property rights of the content belong to the original media source or author. Owing to certain limitations in the translation process, there may be discrepancies between the translated text and the original content. We recommend referring to the original source for complete accuracy. In case of any inaccuracies, we invite you to reach out to us with corrections. If you believe any content has infringed upon your rights, please contact us immediately for its removal.

Malaysian Sabah GOF seizes e-cigarettes, vapes and e-liquids worth over  USD 156,333 in seven-district operation
Malaysian Sabah GOF seizes e-cigarettes, vapes and e-liquids worth over USD 156,333 in seven-district operation
In Sabah, Malaysia’s General Operations Force (GOF) seized thousands of e-cigarette devices, vapes and e-liquids worth more than RM635,000 and detained 23 people during a simultaneous integrated operation across seven districts.
Jan.19 by 2FIRSTS.ai
SICPA Secures Five-Year UK Vape Tax Stamp Contract
SICPA Secures Five-Year UK Vape Tax Stamp Contract
HM Revenue and Customs (HMRC) has awarded a five-year contract to Swiss technology company SICPA and Cartor Security Printers to implement the United Kingdom’s new vaping duty stamp and track-and-trace system, beginning in April 2026.
Market
Feb.24
Oregon Senate Passes Bill to Regulate Nicotine Pouches as Tobacco Products
Oregon Senate Passes Bill to Regulate Nicotine Pouches as Tobacco Products
The Oregon Senate voted 26–1 to pass Senate Bill 1571, a measure redefining tobacco products to include nicotine pouches and restricting their sale to individuals under 21.
Regulations
Feb.23
U.S. Washington State to Bring Synthetic Nicotine Under the Tobacco Tax System, Applying a Unified Tax Starting January 2026
U.S. Washington State to Bring Synthetic Nicotine Under the Tobacco Tax System, Applying a Unified Tax Starting January 2026
Washington State will subject all nicotine-containing products to the Tobacco Products Tax starting January 1, 2026, taxing them at 95% of the selling price. The change covers both tobacco-derived and synthetic nicotine products and requires businesses to report their inventory when the new tax system takes effect.
Dec.29 by 2FIRSTS.ai
Malaysia moves ahead with vape sales ban plan; PMI urges Japan-style differentiated excise taxes
Malaysia moves ahead with vape sales ban plan; PMI urges Japan-style differentiated excise taxes
Malaysia plans to implement a ban or restrictions on e-cigarettes and vaping products as early as mid-2026 and no later than year-end. The head of Philip Morris Malaysia and Singapore said the government should look to Japan’s approach of regulating and taxing different tobacco and nicotine products differently, warning that an outright ban could push demand into illicit channels.
Feb.02
Small ENDS Manufacturers Press FDA on Abuse Liability Standards as Agency Defines Pharmacological Review Framework
Small ENDS Manufacturers Press FDA on Abuse Liability Standards as Agency Defines Pharmacological Review Framework
At the third session of its PMTA roundtable, the FDA outlined its framework for assessing abuse liability in ENDS products, emphasizing the role of nicotine pharmacokinetics and product-specific data in APPH determinations. Small manufacturers questioned the high cost of clinical PK studies and the absence of defined numeric thresholds, while raising bridging strategies and PBPK modeling as potential alternatives.
Feb.11